Halozyme Therapeutics HALO Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from Halozyme Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Halozyme Therapeutics’s 10-Q, filed November 3, 2025, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's price / earnings?
- Halozyme Therapeutics (HALO) reported price / earnings of 14.4× in Q3 2025.
- How has Halozyme Therapeutics's price / earnings changed year-over-year?
- Halozyme Therapeutics's price / earnings decreased by 22.3% year-over-year, from 18.5× to 14.4×.
- What is the long-term trend for Halozyme Therapeutics's price / earnings?
- Over 4 years (2020 to 2024), Halozyme Therapeutics's price / earnings has grown at a -26.0% compound annual growth rate (CAGR), from 45.6× to 13.7×.
- What does price / earnings mean?
- How many dollars investors pay for each dollar of the company's annual profit.
- How do you interpret price / earnings?
- Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
- How does price / earnings compare across companies?
- Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.